TI-Trust’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AIM
FWIA
DLA
ETC
TI-Trust's BMY Position: Q2 2026 in Review
TI-Trust increased its Bristol-Myers Squibb (BMY) stake by 0.21% in Q2 2026, buying an estimated $2.81K and bringing the position to 23,089 shares worth $1.33M. The position accounts for 0.72% of the portfolio, ranked #43.
TI-Trust first reported a position in BMY in Q4 2019 and has held it in 20 quarters since. The position peaked at $1.7M in Q2 2022. 885 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- TI-Trust held 23,089 shares of Bristol-Myers Squibb worth $1.33M as of Q2 2026.
- TI-Trust bought 49 Bristol-Myers Squibb shares in Q2 2026, an estimated $2.81K.
- Bristol-Myers Squibb made up 0.72% of TI-Trust's portfolio in Q2 2026, its #43 holding.
- TI-Trust first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 20 quarters since.
- TI-Trust's Bristol-Myers Squibb position peaked at $1.7M in Q2 2022.
- 885 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on TI-Trust's 13F filing for Q2 2026, filed 23 Jul 2026.